
Contact us
About company
DexTech is a Swedish research company specializing in urological oncology, mainly prostate cancer. DexTech develops drug candidates based on a modified carbohydrate molecule in combination with active substances, including generics. The company has a strong clinical foundation with valuable specialist expertise from research laboratory and manufacturing to clinical oncology.
Unknown
Unknown
Not verified company